Does PIRFENIDONE Cause Second primary malignancy? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Second primary malignancy have been filed in association with PIRFENIDONE (PIRFENIDONE). This represents 0.0% of all adverse event reports for PIRFENIDONE.
6
Reports of Second primary malignancy with PIRFENIDONE
0.0%
of all PIRFENIDONE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Second primary malignancy From PIRFENIDONE?
Of the 6 reports, 3 (50.0%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIRFENIDONE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does PIRFENIDONE Cause?
Death (7,221)
Nausea (4,944)
Fatigue (3,597)
Decreased appetite (3,126)
Diarrhoea (3,026)
Dyspnoea (2,526)
Weight decreased (2,113)
Dizziness (2,027)
Rash (1,982)
Cough (1,692)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which PIRFENIDONE Alternatives Have Lower Second primary malignancy Risk?
PIRFENIDONE vs PIRIBEDIL
PIRFENIDONE vs PIRITRAMIDE
PIRFENIDONE vs PIROXICAM
PIRFENIDONE vs PIRTOBRUTINIB
PIRFENIDONE vs PIT VIPER IMMUNE GLOBULIN ANTIVENIN